Alto Pharmacy Secures $50 Million in Series C Funding to Accelerate U.S. Expansion, Deliver New Complex Therapeutics SAN FRANCISCO, December 5, 2018-- Alto, a leader in modern pharmacy, today announced it has raised $50 million in Series C funding in a round led by Zola Global and Greenoaks Capital with participation from Jackson Square Ventures, Olive Tree Capital, and others. This funding round will support geographic expansion into new markets across the U.S. and deliver new products for chronic and complex therapeutic areas. To date, Alto has raised a total of $73 million.